Genetic effects on longitudinal changes from healthy to adverse weight and metabolic status - The HUNT study

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Kvaløy, Kirsti ^a   Holmen, Jostein ^a   Hveem, Kristian ^a   Holmen, Turid Lingaas ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ALPHA KETOGLUTARATE DEPENDENT DIOXYGENASE FTO; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; APOLIPOPROTEIN A5; DOPAMINE 2 RECEPTOR; DRD2 PROTEIN, HUMAN; FTO PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; PROTEIN;

ADULT; APOA5 GENE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DNA EXTRACTION; DOPAMINERGIC SYSTEM; DRD2 GENE; EATING DISORDER; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC TRAIT; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GRB14 GENE; HUMAN; LONGITUDINAL STUDY; LPL GENE; MALE; METABOLIC DISORDER; OBESITY; PLEIOTROPY; REGRESSION ANALYSIS; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ZNF259 GENE; ADOLESCENT; ANALYSIS; BLOOD; BLOOD PRESSURE; BODY MASS; COMPLICATION; GENETICS; METABOLIC SYNDROME X; MIDDLE AGED; WEIGHT GAIN; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO; APOLIPOPROTEIN A-V; APOLIPOPROTEINS A; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RECEPTORS, DOPAMINE D2; TRIGLYCERIDES; WEIGHT GAIN; YOUNG ADULT;

EID: 84948703831     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139632     Document Type: Article

References (53)

1. Kopelman PG. Obesity as a medical problem. Nature. 2000; 404(6778):635-43. Epub 2000/04/15. doi: 10.1038/35007508 PMID: 10766250.
2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003; 289(1):76-9. Epub 2002/12/31. PMID: 12503980.
3. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011; 377 (9765):557-67. Epub 2011/02/08. doi: 10.1016/s0140-6736(10)62037-5 PMID: 21295846.
4. Midthjell K, Lee CM, Langhammer A, Krokstad S, Holmen TL, Hveem K, et al. Trends in overweight and obesity over 22 years in a large adult population: the HUNT Study, Norway. Clin Obes. 2013; 3(1-2):12-20. Epub 2013/08/13. doi: 10.1111/cob.12009 PMID: 23935708; PubMed Central PMCID: PMC3734732.
5. Elks CE, den Hoed M, Zhao JH, Sharp SJ, Wareham NJ, Loos RJ, et al. Variability in the heritability of body mass index: a systematic review and meta-regression. Front Endocrinol (Lausanne). 2012; 3:29. Epub 2012/05/31. doi: 10.3389/fendo.2012.00029 PMID: 22645519; PubMed Central PMCID: PMC3355836.
6. Loos RJ. Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab. 2012; 26(2):211-26. Epub 2012/04/14. doi: 10.1016/j.beem.2011.11.003 PMID: 22498250.
7. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010; 42 (11):937-48. Epub 2010/10/12. doi: 10.1038/ng.686 PMID: 20935630; PubMed Central PMCID: PMC3014648.
8. Falchi M, El-Sayed Moustafa JS, Takousis P, Pesce F, Bonnefond A, Andersson-Assarsson JC, et al. Low copy number of the salivary amylase gene predisposes to obesity. Nat Genet. 2014. Epub 2014/04/02. doi: 10.1038/ng.2939 PMID: 24686848.
9. Flannick J, Thorleifsson G, Beer NL, Jacobs SB, Grarup N, Burtt NP, et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet. 2014; 46(4):357-63. Epub 2014/03/04. doi: 10. 1038/ng.2915 PMID: 24584071.
10. Steinthorsdottir V, Thorleifsson G, Sulem P, Helgason H, Grarup N, Sigurdsson A, et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat Genet. 2014; 46(3):294-8. Epub 2014/01/28. doi: 10.1038/ng.2882 PMID: 24464100.
11. Schwenk RW, Vogel H, Schurmann A. Genetic and epigenetic control of metabolic health. Mol Metab. 2013; 2(4):337-47. Epub 2013/12/12. doi: 10.1016/j.molmet.2013.09.002 PMID: 24327950; PubMed Central PMCID: PMC3854991.
12. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006; 23(5):469-80. Epub 2006/05/10. doi: 10.1111/j.1464-5491.2006.01858.x PMID: 16681555.
13. van Dongen J, Willemsen G, Chen WM, de Geus EJ, Boomsma DI. Heritability of metabolic syndrome traits in a large population-based sample. J Lipid Res. 2013; 54(10):2914-23. Epub 2013/08/07. doi: 10.1194/jlr.P041673 PMID: 23918046; PubMed Central PMCID: PMC3770104.
14. Wagner GP, Zhang J. The pleiotropic structure of the genotype-phenotype map: the evolvability of complex organisms. Nat Rev Genet. 2011; 12(3):204-13. Epub 2011/02/19. doi: 10.1038/nrg2949 PMID: 21331091.
15. Kullo IJ, de Andrade M, Boerwinkle E, McConnell JP, Kardia SL, Turner ST. Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships. Am J Hypertens. 2005; 18(1):99-103. Epub 2005/02/05. doi: 10.1016/j.amjhyper.2004. 09.002 PMID: 15691623.
16. Andreassen OA, McEvoy LK, Thompson WK, Wang Y, Reppe S, Schork AJ, et al. Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes. Hypertension. 2014; 63(4):819-26. Epub 2014/01/08. doi: 10.1161/hypertensionaha.113.02077 PMID: 24396023.
17. Volkow ND, Wang GJ, Tomasi D, Baler RD. The addictive dimensionality of obesity. Biol Psychiatry. 2013; 73(9):811-8. Epub 2013/02/05. doi: 10.1016/j.biopsych.2012.12.020 PMID: 23374642.
18. Alsio J, Olszewski PK, Levine AS, Schioth HB. Feed-forward mechanisms: addiction-like behavioral and molecular adaptations in overeating. Front Neuroendocrinol. 2012; 33(2):127-39. Epub 2012/02/07. doi: 10.1016/j.yfrne.2012.01.002 PMID: 22305720.
19. Carpenter CL, Wong AM, Li Z, Noble EP, Heber D. Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity. Obesity (Silver Spring). 2013; 21(9):E467-73. Epub 2013/05/15. doi: 10.1002/oby.20202 PMID: 23670889.
20. Stice E, Yokum S, Bohon C, Marti N, Smolen A. Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4. Neuroimage. 2010; 50(4):1618-25. Epub 2010/02/02. doi: 10.1016/j.neuroimage.2010.01.081 PMID: 20116437.
21. Heber D, Carpenter CL. Addictive Genes and the Relationship to Obesity and Inflammation. Mol Neurobiol. 2011; 44(2):160-5. doi: 10.1007/s12035-011-8180-6 PMID: 21499988; PubMed Central PMCID: PMC2793113.
22. Hertel JK, Johansson S, Sonestedt E, Jonsson A, Lie RT, Platou CG, et al. FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes. 2011; 60(5):1637-44. Epub 2011/03/15. doi: 10.2337/db10-1340 PMID: 21398525; PubMed Central PMCID: PMC3292341.
23. Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, et al. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care. 2012; 35(2):363-6. Epub 2011/12/20. doi: 10.2337/dc11-1328 PMID: 22179955; PubMed Central PMCID: PMC3263869.
24. Hong CJ, Liou YJ, Bai YM, Chen TT, Wang YC, Tsai SJ. Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment. Pharmacogenet Genomics. 2010; 20(6):359-66. Epub 2010/04/09. PMID: 20375926.
25. Krokstad S, Langhammer A, Hveem K, Holmen T, Midthjell K, Stene T, et al. Cohort Profile: The HUNT Study, Norway. Int J Epidemiol. 2012. Epub 2012/08/11. doi: 10.1093/ije/dys095 PMID: 22879362.
26. Kvaloy K, Kulle B, Romundstad P, Holmen TL. Sex-specific effects of weight-affecting gene variants in a life course perspective - The HUNT Study, Norway. Int J Obes (Lond). 2013; 37(9):1221-9. Epub 2013/01/16. doi: 10.1038/ijo.2012.220 PMID: 23318717.
27. Begum G, Davies A, Stevens A, Oliver M, Jaquiery A, Challis J, et al. Maternal undernutrition programs tissue-specific epigenetic changes in the glucocorticoid receptor in adult offspring. Endocrinology. 2013; 154(12):4560-9. Epub 2013/09/26. doi: 10.1210/en.2013-1693 PMID: 24064364.
28. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014; 14(1):9. Epub 2014/02/04. doi: 10.1186/1472-6823-14-9 PMID: 24484869; PubMed Central PMCID: PMC3923238.
29. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000; 320(7244):1240-3. Epub 2000/05/08. PMID: 10797032; PubMed Central PMCID: PMC27365 child overweight and obesity, specifying the measurement, reference population, and age and sex specific cut off points. Data on body mass index (weight/height) were obtained from 6 large nationally representative cross sectional surveys on growth from Brazil, Great Britain, Hong Kong, the Netherlands, Singapore, and the US. The study included 97,876 males and 94,851 females from birth to 25 years of age. For each of the surveys, centile curves were drawn that at age 18 years passed through the widely used cut-off points of 25 and 30 kg/sq. m for adult weight and obesity. The resulting curves were averaged to provide age-and sex-specific cut-off points from 2 to 18 years. The proposed cut off points, which are less arbitrary and more internationally based than current alternatives, should help to provide internationally comparable prevalence rates of overweight and obesity in children.
30. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. Epub 2001/05/23. PMID: 11368702.
31. Sidhu D, Naugler C. Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med. 2012; 172(22):1707-10. Epub 2012/11/14. doi: 10.1001/archinternmed.2012. 3708 PMID: 23147400.
32. Cuypers KF, Loos RJ, Kvaloy K, Kulle B, Romundstad P, Holmen TL. Obesity-susceptibility loci and their influence on adiposity-related traits in transition from adolescence to adulthood - The HUNT study. PLoS One. 2012; 7(10):e46912. Epub 2012/10/25. doi: 10.1371/journal.pone.0046912 PMID: 23094032; PubMed Central PMCID: PMC3477114.
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet. 2007; 81(3):559-75. Epub 2007/08/19. doi: 10.1086/519795 PMID: 17701901; PubMed Central PMCID: PMC1950838.
34. Zhang Z, Hao CJ, Li CG, Zang DJ, Zhao J, Li XN, et al. Mutation of SLC35D3 Causes Metabolic Syndrome by Impairing Dopamine Signaling in Striatal D1 Neurons. PLoS Genet. 2014; 10(2):e1004124. Epub 2014/02/20. doi: 10.1371/journal.pgen.1004124 PMID: 24550737; PubMed Central PMCID: PMC3923682.
35. Stice E, Figlewicz DP, Gosnell BA, Levine AS, Pratt WE. The contribution of brain reward circuits to the obesity epidemic. Neurosci Biobehav Rev. 2013; 37(9 Pt A):2047-58. Epub 2012/12/15. doi: 10.1016/j. neubiorev.2012.12.001 PMID: 23237885; PubMed Central PMCID: PMC3604128.
36. Hardy R. Life course variations in the associations between FTO and MC4R gene variants and body size. Hum Mol Genet. 2010; 19:545-52. doi: 10.1093/hmg/ddp504 PMID: 19880856
37. Huang T, Qi Q, Li Y, Hu FB, Bray GA, Sacks FM, et al. FTO genotype, dietary protein, and change in appetite: the Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr. 2014; 99 (5):1126-30. Epub 2014/03/14. doi: 10.3945/ajcn.113.082164 PMID: 24622803; PubMed Central PMCID: PMC3985215.
38. Karra E. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest. 2013; 123:3539-51. doi: 10.1172/JCI44403 PMID: 23867619
39. Jacobsson JA, Danielsson P, Svensson V, Klovins J, Gyllensten U, Marcus C, et al. Major gender difference in association of FTO gene variant among severely obese children with obesity and obesity related phenotypes. Biochem Biophys Res Commun. 2008; 368(3):476-82. Epub 2008/02/06. doi: 10. 1016/j.bbrc.2008.01.087 PMID: 18249188.
40. van Vliet-Ostaptchouk JV, den Hoed M, Luan J, Zhao JH, Ong KK, van der Most PJ, et al. Pleiotropic effects of obesity-susceptibility loci on metabolic traits: a meta-analysis of up to 37,874 individuals. Diabetologia. 2013; 56(10):2134-46. Epub 2013/07/06. doi: 10.1007/s00125-013-2985-y PMID: 23827965.
41. Yamada Y, Ando F, Shimokata H. Association of the genetic variants of APOA5 and PRKCH with hypertension in community-dwelling Japanese individuals. Mol Med Rep. 2008; 1(3):407-14. Epub 2008/05/01. PMID: 21479425.
42. Kristiansson K, Perola M, Tikkanen E, Kettunen J, Surakka I, Havulinna AS, et al. Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet. 2012; 5 (2):242-9. Epub 2012/03/09. doi: 10.1161/circgenetics.111.961482 PMID: 22399527; PubMed Central PMCID: PMC3378651.
43. Comuzzie AG, Cole SA, Laston SL, Voruganti VS, Haack K, Gibbs RA, et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One. 2012; 7(12): e51954. Epub 2012/12/20. doi: 10.1371/journal.pone.0051954 PMID: 23251661; PubMed Central PMCID: PMC3522587.
44. Shen Y, Xi B, Zhao X, Cheng H, Hou D, Wu L, et al. Common genetic variants associated with lipid profiles in a Chinese pediatric population. Hum Genet. 2013; 132(11):1275-85. Epub 2013/07/09. doi: 10. 1007/s00439-013-1332-1 PMID: 23832694.
45. Zhang X, Qi Q, Bray GA, Hu FB, Sacks FM, Qi L. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial. Am J Clin Nutr. 2012; 96(4):917-22. Epub 2012/08/24. doi: 10.3945/ajcn.112.040907 PMID: 22914552; PubMed Central PMCID: PMC3441115.
46. Walia GK, Gupta V, Aggarwal A, Asghar M, Dudbridge F, Timpson N, et al. Association of common genetic variants with lipid traits in the Indian population. PLoS One. 2014; 9(7):e101688. Epub 2014/07/06. doi: 10.1371/journal.pone.0101688 PMID: 24991929; PubMed Central PMCID: PMC4081649.
47. Ariza MJ, Sanchez-Chaparro MA, Baron FJ, Hornos AM, Calvo-Bonacho E, Rioja J, et al. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study. BMC Med Genet. 2010; 11:66. Epub 2010/05/01. doi: 10. 1186/1471-2350-11-66 PMID: 20429872; PubMed Central PMCID: PMC2877669.
48. Franceschini N, Carty C, Buzkova P, Reiner AP, Garrett T, Lin Y, et al. Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study. Circ Cardiovasc Genet. 2011; 4(6):661-72. Epub 2011/11/02. doi: 10.1161/circgenetics.111.960096 PMID: 22042884; PubMed Central PMCID: PMC3293207.
49. Lu Y, Dolle ME, Imholz S, van 't Slot R, Verschuren WM, Wijmenga C, et al. Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. J Lipid Res. 2008; 49(12):2582-9. Epub 2008/07/29. doi: 10.1194/jlr.M800232-JLR200 PMID: 18660489.
50. Sagoo GS, Tatt I, Salanti G, Butterworth AS, Sarwar N, van Maarle M, et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol. 2008; 168(11):1233-46. Epub 2008/10/17. doi: 10.1093/aje/kwn235 PMID: 18922999.
51. Park JY, Mitrou PN, Keogh RH, Luben RN, Wareham NJ, Khaw KT. Effects of body size and sociodemographic characteristics on differences between self-reported and measured anthropometric data in middle-aged men and women: the EPIC-Norfolk study. Eur J Clin Nutr. 2011; 65(3):357-67. Epub 2010/12/24. doi: 10.1038/ejcn.2010.259 PMID: 21179050.
52. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njolstad I. Cohort profile: the Tromso Study. Int J Epidemiol. 2012; 41(4):961-7. Epub 2011/03/23. doi: 10.1093/ije/dyr049 PMID: 21422063; PubMed Central PMCID: PMCPmc3429870.
53. Scholtens S, Smidt N, Swertz MA, Bakker SJ, Dotinga A, Vonk JM, et al. Cohort Profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2014. Epub 2014/12/17. doi: 10.1093/ije/dyu229 PMID: 25502107.